MARLY JIBY: Open Payments
NPI 1922591783 · FLEMINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 5 payments from 5 companies in 2025. Trend: 2023 $411 · 2024 $838 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $108 |
| ABBVIE INC. | 1 | $82 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: FANAPT, ABILIFY ASIMTUFII, VRAYLAR, COBENFY, INGREZZA.
Industry payments across NJ — which companies pay providers there.
